Navigation Links
EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
Date:10/16/2009

WELLESLEY Hills, Mass., Oct. 16 /PRNewswire/ -- The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4 partial agonist for the potential treatment of Alzheimer's Disease. The patient was enrolled initially in a two week Phase 2a study in August 2007 where she received 100 mg per day of PRX-03140 in combination with her normal daily dose of Aricept(®)(10 mg). Based on the marked progress during the original two week study, the patient's daughter sought continued compassionate use of PRX-03140 for her mother and a protocol was submitted to the FDA and approved. The progress seen in the first 2-week study has continued during the past two years (19 months of dosing) and four FDA approved 6-month open label extensions. The latest open label extension will be administered under a new Physician-Sponsored IND under the supervision of Dr. Lucy Hornstein(1). "When I was approached by the patient's daughter to continue the compassionate use therapy of PRX-03140 for her mother, I was compelled by the progress her mother had experienced and the overall apparent safety of the drug," notes Dr. Hornstein.

On July 20, 2009, EPIX Pharmaceuticals, Inc. (the "Company") entered into an Assignment for the Benefit of Creditors (the "Assignment") in accordance with Massachusetts law. The purpose of the Assignment is to conclude the Company's operations and provide for an orderly liquidation of its assets. The Assignment is a common law business liquidation mechanism under Massachusetts law that is an alternative to a formal bankruptcy proceeding. Under the terms of the Assignment, the Company transferred all of its assets to an assignee for orderly liquidation and distribution of the proceeds to the Company's creditors. The designated assignee for the Company is Joseph F. Finn, Jr. at Finn, Warnke & Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481.

The
'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
2. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
3. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
4. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
5. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
6. China Yongxin Pharmaceuticals Inc. Announces Second Quarter 2009 Financial Results
7. VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
8. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
9. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
11. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... Aug. 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... completed the acquisition of leading OTC brands from GSK ... The transaction is a clear demonstration of Perrigo,s unique ... European distribution network spanning 36 countries.  ... commented, "We are excited to complete this transaction, ...
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
... Wash., April 23 Archus Orthopedics, Inc.,announced today ... implant,of its TFAS-C(TM) system, the newest addition to ... condition in which degenerative changes in,the facet joints ... in the legs. Traditionally, patients with moderate to,severe ...
... LOUISVILLE, Colo., April 23 Replidyne, Inc.,(Nasdaq: ... enrollment in a,placebo-controlled Phase III clinical trial testing ... chronic bronchitis,(AECB). Replidyne took this action to conserve ... strategic transactions and maintaining,its research programs., The ...
Cached Medicine Technology:First Human Implant of New Archus Orthopedics Facet Replacement System 2Replidyne Discontinues Phase III Trial 2Replidyne Discontinues Phase III Trial 3
(Date:8/30/2015)... , ... August 30, 2015 , ... Natural Rest contains ... effects as sleep aids and calming remedies, which help to improve mood disorders and ... a great deal of research in the field of regenerative medicine conducted by Dr. ...
(Date:8/30/2015)... ... 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ) ... Assistant to CEO Mitch Gould for Nutritional Products International. Through all methods ... Kathleen graduated from Florida State University with a Bachelor of Science in Business ...
(Date:8/29/2015)... ... 30, 2015 , ... On September 30, 2015, the Career and Transfer Center ... accredited Maricopa Community Colleges , will be hosting a Job Expo to provide ... and opportunities. , The Expo has expanded to much more than just a typical ...
(Date:8/29/2015)... ... August 29, 2015 , ... "I have ... Miller Place, N.Y. "I specialize in manual therapy, and my invention will provide ... be used for additional muscle dysfunction throughout the body." , They developed THE ...
(Date:8/29/2015)... ... 2015 , ... Dr. Tim Novelli, DC., Founder and President of the Patriot ... of the chiropractic field in the military. All too often VA hospitals treat patients ... made available to the VA program over a decade ago, the reality is that ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2
... for Patients, Nurse Staffing and Cost Savings , ... introduced today by Sen. Al Franken (D-Minn.) will not only ... other health care facilities, but also will ensure patients get ... safest way possible, all while improving the bottom line for ...
... Subaru of America is joining the San Francisco Hep B ... the use of a 2010 Subaru Legacy detailed with full ... to "B a Hero" in preventing liver cancer and the ... ) , Hepatitis B causes up to 80 percent ...
... Austin City Limits music festival concluded, spa professionals from ... for the 19th annual International SPA Association Conference & ... participated in educational sessions, learned about the newest products ... Conference theme, "Simplify," resonated with attendees as they discussed ...
... Oct. 15 Hematopoietic stem cell transplantation (HSCT) and ... invasive fungal infections (IFIs). IFIs are a significant cause ... in the epidemiology of IFIs have led to an ... of which are linked to poor outcomes in patients. ...
... King of Prussia location to support Breast Cancer Awareness , ... a whole new twist. Nordstrom,s Department Store and non-profit ... to "bedazzle" their bras. Entries will be on display in ... PA on Saturday, October 17th from 11 a.m. until 5 p.m. ...
... -- Mayo Clinic clinicians and designers, along with ... a tool to involve patients more in their ... set of decision aid cards, could help patients ... to better outcomes. The results of this randomized ...
Cached Medicine News:Health News:Nation's RNs Hail Sen. Franken's Support for Safe Patient Handling Measure 2Health News:Subaru Donates 'Hep B Hero Mobile' to Support Campaign 2Health News:Subaru Donates 'Hep B Hero Mobile' to Support Campaign 3Health News:2009 ISPA Conference & Expo Rocks Out With Lance Armstrong in Austin 2Health News:Invasive Fungal Infections in HSCT Recipients: Improving Outcomes Through Prevention and Treatment 2Health News:Bedazzled Bras Benefit Breastcancer.org 2Health News:Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients 2Health News:Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients 3
Custom-made chisels....
9 inch sharp bone hook with grip handle....
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation....
Straight, single action bone forceps to excise, trim and sculpt bone....
Medicine Products: